Peptide High Quality ll-37 Powder CAS. 597562-32-8 99% Purity

1.  Description

     Antibacterial Acne-Fighting Products: LL-37 is suitable for oily acne-prone skin, inflammatory acne (red, swollen pimples, pustules), and individuals with recurring breakouts. It is used to develop acne-fighting serums, anti-inflammatory gels, acne repair essences, acne-fighting masks, and similar products. Formulation Logic: LL-37 (0.01%-0.05% concentration) + Salicylic Acid (0.5%-1% mild concentration) + Niacinamide (2%-3%) + Tea Tree Essential Oil (0.1%-0.2%) LL-37 targets and inhibits Propionibacterium acnes and Staphylococcus aureus, salicylic acid unclogs pores, and niacinamide regulates sebum production. This synergistic approach delivers quadruple benefits: antibacterial + oil control + anti-inflammatory + acne reduction, while avoiding the drug resistance issues associated with traditional acne-fighting ingredients.

     Sensitive Skin & Barrier Repair Products: LL-37 targets rosacea, steroid-dependent dermatitis, and seasonal sensitivity, used in soothing repair creams, redness-relief serums, and anti-inflammatory sprays; Formulation Design: LL-37 (0.005%-0.01%) + Ceramide NP (0.2%-0.3%) + Panthenol (2%-3%) + Ectoin (1%-2%) LL-37 inhibits inflammatory factor release to alleviate redness and itching, while ceramides and panthenol rebuild the skin barrier, providing long-term stability for fragile skin.

     Post-Medical Aesthetics / Chemical Peel Repair Products: LL-37 is suitable for developing repair freeze-dried powders and post-procedure soothing serums following treatments like photorejuvenation, chemical peels, and microneedling. Combination logic: LL-37 (0.01%-0.03%) + Centella Asiatica Extract (0.3%-0.5%) + Sodium Hyaluronate (0.5%-1%). LL-37 suppresses post-procedure inflammation, shortens redness recovery time, prevents post-inflammatory hyperpigmentation and infection risks, while Centella Asiatica accelerates damaged epidermal repair.

     Scalp Health Care Products: LL-37 targets individuals with seborrheic dermatitis, itchy scalp with dandruff (Malassezia infection), and scalp acne. It is used to develop anti-inflammatory and antibacterial shampoos and scalp repair serums. Combination Logic: LL-37 (0.01%-0.03%) + Zinc Pyrithione (0.5%-1%) + Menthol (0.1%-0.2%). LL-37 suppresses pathogenic bacteria and inflammation on the scalp, while pyrithione zinc regulates scalp microbiome balance to alleviate itching and dandruff, suitable for oily and sensitive scalps.

2.  Application

     Topical Antimicrobial Formulations for Skin Infections: LL-37 serves as an active ingredient for topical antimicrobial agents, used in developing ointments, gels, and sprays to treat bacterial skin infections (impetigo, folliculitis) and fungal skin infections (tinea manuum/pedis, tinea corporis). It is suitable for individuals with infections resistant to traditional antibiotics, particularly children and patients with sensitive skin.

     Mucosal Inflammation and Infection Treatment: LL-37 is used to develop topical formulations (mouthwashes, gels, suppositories) for oral mucosal inflammation (canker sores) and genital tract mucosal infections (vaginitis). It alleviates mucosal redness, swelling, pain, and ulcer symptoms through localized antibacterial and anti-inflammatory action.

     Wound Healing Formulations: Development of repair gels and dressings for burns, trauma, and surgical incisions. LL-37 combines antimicrobial (infection prevention) and reparative (granulation tissue growth promotion) functions to accelerate wound healing and reduce scar hyperplasia risk.

     Research Tools & Reagents: LL-37 is utilized in studies of antimicrobial mechanisms and immune regulatory pathways (e.g., bacterial resistance models, inflammation models). As a tool peptide, it provides experimental evidence for the development of novel antimicrobial and anti-inflammatory drugs.

3. Main Efficacy

     Broad-spectrum antimicrobial efficacy (core advantage): LL-37 operates through a dual mechanism of “physical disruption + targeted inhibition” — ① Cationic peptides bind to bacterial cell membranes (anionic phospholipid bilayers), forming transmembrane pores that cause bacterial contents to leak out, leading to cell death; ② Inhibits biofilm formation, blocking bacterial adhesion and proliferation. Antimicrobial spectrum covers Gram-positive bacteria (Staphylococcus aureus, Propionibacterium acnes), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa), fungi (Malassezia, Candida albicans), and certain viruses (Herpes simplex virus), with no resistance development (does not induce bacterial resistance gene expression). Antimicrobial activity persists longer than traditional antibiotics.

     Anti-inflammatory and Immunomodulatory Effects: LL-37 downregulates the transcription and release of pro-inflammatory factors (TNF-α, IL-6, IL-1β), blocking the inflammatory cascade; simultaneously, it activates the expression of anti-inflammatory factors (IL-10), balancing the skin's immune microenvironment. Additionally, it modulates immune cell (macrophage, neutrophil) activity to enhance skin's innate defense capabilities. Visible relief from redness and swelling in rosacea and inflammatory acne occurs within 1-2 days of application.

     Skin Barrier Repair and Wound Healing Effects: LL-37 promotes proliferation and differentiation of skin keratinocytes and fibroblasts, accelerating epidermal regeneration. It stimulates synthesis of ceramides, keratin, and collagen to reconstruct the skin lipid barrier, reducing transepidermal water loss (TEWL). In wound repair, it promotes angiogenesis and granulation tissue growth, shortening the healing cycle by over 30% while reducing excessive scar tissue proliferation.

     Safety Advantages: As an endogenous antimicrobial peptide in the human body, LL-37 exhibits exceptional compatibility with skin cells, lacks immunogenicity, and does not trigger allergic or rejection reactions. Skin irritation testing (HRIPT) confirms non-sensitizing properties, while cytotoxicity testing (MTT) shows skin cell survival rates exceeding 98% at concentrations ≤0.05%. Long-term use carries no side effects such as hormone dependency, skin atrophy, or dysbiosis, making it suitable for sensitive skin, pregnant women, children, and other special populations. It is listed in the EU CosIng database and China's Catalogue of Cosmetic Ingredients in Use (2021 Edition), ensuring strong regulatory compliance.